| Serial Number | 98128117 |
| Word Mark | KAMAU THERAPEUTICS |
| Filing Date | Friday, August 11, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, March 27, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 13, 2024 |
| Goods and Services | Pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations in the nature of genetically modified cells for use in the treatment of genetic diseases and disorders; pharmaceutical preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for gene therapy, gene editing, genome editing, and targeted gene replacement and insertion; cell therapy products in the nature of genetically modified cells for the treatment of genetic diseases and disorders; gene therapy products in the nature of genetically engineered human genes for the treatment of genetic diseases and disorders; pharmaceutical preparations for non-genotoxic conditioning to enable engraftment; pharmaceutical preparations containing templates of DNA sequences to restore and normalize the function in a disease-causing gene; gene edited and corrected human cells for medical use |
| NOT AVAILABLE | THERAPEUTICS |
| Goods and Services | Pharmaceutical research and development services; Research in the fields of pharmaceuticals, gene regulation, gene modification, gene correction, cell therapy, gene therapy, genetic diseases and disorders, and templates containing DNA sequences, and targeted gene replacement and insertion; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; research and development of therapeutics pharmaceuticals using gene editing; providing medical and scientific research information in the field of pharmaceuticals, gene regulation, gene modification, gene correction, cell therapy, gene therapy, genetic diseases and disorders, and templates containing DNA sequences, and targeted gene replacement and insertion; research in the field of clustered regularly interspaced short palindromic repeats (CRISPR) and homology directed repair (HDR) technologies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 11, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 11, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kamau Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Kamau Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Monday, September 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 15, 2023 | NEW APPLICATION ENTERED |
| Friday, April 12, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 17, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 17, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 21, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 21, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 26, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 26, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 26, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, June 26, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Friday, July 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 13, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 13, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 8, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, March 27, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 27, 2025 | SOU EXTENSION 1 FILED |
| Thursday, March 27, 2025 | SOU EXTENSION 1 GRANTED |
| Friday, March 28, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |